Review Articles Concerning Pulmonary Vascular Disease

A Cross-Species and Sex-Specific Meta-Analysis of Transcriptomic Studies of Pulmonary Hypertension

Lan Zhao, Christine M. Cunningham, Jason Hong, Stuti Agarwal, Ke Yuan, Vinicio A. de Jesus Perez, Mark R. NicollsStanford University. University of California, Los Angeles. Boston Children’s Hospital.United States American Journal of Respiratory Cell and Molecular BiologyAm J Respir Cell Mol Biol 2025; DOI: 10.1165/rcmb.2024-0410OC AbstractPulmonary hypertension (PH) is a life-threatening disease characterized by pulmonary vascular […]

A Cross-Species and Sex-Specific Meta-Analysis of Transcriptomic Studies of Pulmonary Hypertension Read More »

Preterm Infants With Bronchopulmonary Dysplasia and Pulmonary Hypertension

Kathryn Hasselfeld, Erik Hysinger, Melissa HouseCincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine. Children’s Healthcare of Atlanta and Emory School of Medicine.United States NeoreviewsNeoreviews 2025; 26: e132-e140DOI: 10.1542/neo.26-2-015 AbstractAbstract Not Available CategoryClass III. Pulmonary Hypertension Associated with Lung DiseaseReview Articles Concerning Pulmonary Vascular Disease Age Focus: Pediatric Pulmonary Vascular Disease Fresh or

Preterm Infants With Bronchopulmonary Dysplasia and Pulmonary Hypertension Read More »

Pulmonary vascular complications of cirrhosis: hepatopulmonary syndrome and portopulmonary hypertension

Maïté Verstraeten, Sander Lefere, Sarah RaevensGhent University Hospital and Ghent University.Belgium Acta Clinica BelgicaActa Clin Belg 2025; DOI: 10.1080/17843286.2025.2456697 AbstractHepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) are two distinct pulmonary vascular complications seen in patients with liver disease and/or portal hypertension. HPS is characterized by disturbed gas exchange and hypoxemia because of intrapulmonary vascular dilatations. POPH

Pulmonary vascular complications of cirrhosis: hepatopulmonary syndrome and portopulmonary hypertension Read More »

Risk Assessment and Monitoring of Chronic Pulmonary Hypertension in Premature Infants

Philip T. Levy, Amish Jain, Hythem Nawaytou, David Teitel, Roberta Keller, Jeffery Fineman, Robin Steinhorn, Steven H. Abman, Patrick J. McNamara, for the Pediatric Pulmonary Hypertension Network (PPHNet)Boston Children’s Hospital and Harvard Medical School. University of Toronto and Mount Sinai Hospital. University of California, San Francisco. Children’s National Health System. University of Colorado Anschutz Medical

Risk Assessment and Monitoring of Chronic Pulmonary Hypertension in Premature Infants Read More »

Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia

Usha Krishnan, Jeffrey A. Feinstein, Ian Adatia, Eric D. Austin, Mary P. Mullen, Rachel K. Hopper, Brian Hanna, Lew Romer, Roberta L. Keller, Jeffrey Fineman, Robin Steinhorn, John P. Kinsella, D. Dunbar Ivy, Erika Berman Rosenzweig, Usha Raj, Tilman Humpl, Steven H. Abman, for the Pediatric Pulmonary Hypertension Network (PPHNet)Columbia University Medical Center and Morgan

Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia Read More »

The Role of Imaging in Pulmonary Vascular Disease: The Clinician’s Perspective

Brandon R. Jakubowski, Megan Griffiths, Kara N. GossUniversity of Texas Southwestern Medical Center.United States Radiology Clinics of North AmericaRadiol Clin North Am 2025; 63: 305-313DOI: 10.1016/j.rcl.2024.07.008 AbstractPulmonary vascular diseases, particularly when accompanied by pulmonary hypertension, are complex disorders often requiring multimodal imaging for diagnosis and monitoring. Echocardiography is the primary screening tool for pulmonary hypertension, while

The Role of Imaging in Pulmonary Vascular Disease: The Clinician’s Perspective Read More »

Novel Therapies for Right Ventricular Failure

Bibhuti B. DasUniversity of Mississippi Medical Center.United States Current Cardiology ReportsCurr Cardiol Rep 2025; 27:DOI: 10.1007/s11886-024-02157-9 AbstractPurpose of review: Traditionally viewed as a passive player in circulation, the right ventricle (RV) has become a pivotal force in hemodynamics. RV failure (RVF) is a recognized complication of primary cardiac and pulmonary vascular disorders and is associated with a

Novel Therapies for Right Ventricular Failure Read More »

[Prognosis of bronchopulmonary dysplasia]

Ying-Zhen Zhou, Ting Wang, Xing-Meng Fu, Bing-Ming Peng, Zhou FuChildren’s Hospital of Chongqing Medical University and National Clinical Research Center for Child Health and Disorders.China Chinese Journal of Contemporary PediatricsZhongguo Dang Dai Er Ke Za Zhi 2025; 27: 115-120DOI: 10.7499/j.issn.1008-8830.2406004 AbstractChildren with bronchopulmonary dysplasia (BPD) often exhibit severe respiratory problems and significant pulmonary dysfunction during school

[Prognosis of bronchopulmonary dysplasia] Read More »

Amniotic fluid stem cell extracellular vesicles as a novel fetal therapy for pulmonary hypoplasia: a review on mechanisms and translational potential

Fabian Doktor, Lina Antounians, Rebeca Lopes Figueira, Kasra Khalaj, Miriam Duci, Augusto ZaniHospital for Sick Children and University of Toronto. Leipzig University.Canada and Germany Stem Cells Translational MedicineStem Cells Transl Med 2025; 14: DOI: 10.1093/stcltm/szae095 AbstractDisruption of developmental processes affecting the fetal lung leads to pulmonary hypoplasia. Pulmonary hypoplasia results from several conditions including congenital diaphragmatic

Amniotic fluid stem cell extracellular vesicles as a novel fetal therapy for pulmonary hypoplasia: a review on mechanisms and translational potential Read More »

Sotatercept: A New Era in Pulmonary Arterial Hypertension

Suneesh C. Anand, Muhammad Furqan, Adriano R. Tonelli, Daniela Brady, Avi Levine, Erika B. Rosenzweig, William H. Frishman, Wilbert S. Aronow, Gregg M. LanierHillcrest Hospital and Cleveland Clinic. New York Medical College, Maria Fareri Children’s Hospital of Westchester and  Westchester Medical Center.United States Cardiology in ReviewCardiol Rev 2025; DOI: 10.1097/CRD.0000000000000837 AbstractPulmonary arterial hypertension (PAH) is a

Sotatercept: A New Era in Pulmonary Arterial Hypertension Read More »

Scroll to Top